Baseline Soluble Anti-erythropoietin Antibody Level Is an Independent Associated Factor for Follow-Up Erythropoietin Demand in Maintenance Dialysis Patients With End-Stage Renal Disease: A Prospective Cohort Study

MLA

Ying Zhang, et al. “Baseline Soluble Anti-Erythropoietin Antibody Level Is an Independent Associated Factor for Follow-Up Erythropoietin Demand in Maintenance Dialysis Patients With End-Stage Renal Disease: A Prospective Cohort Study.” Frontiers in Medicine, vol. 7, Apr. 2020. EBSCOhost, https://doi.org/10.3389/fmed.2020.00109.

APA

Ying Zhang, Shi-Zhu Bian, Kun Yang, Yiqing Wang, Sha Tang, Weili Wang, Daihong Wang, Ling Nie, & Jinghong Zhao. (2020). Baseline Soluble Anti-erythropoietin Antibody Level Is an Independent Associated Factor for Follow-Up Erythropoietin Demand in Maintenance Dialysis Patients With End-Stage Renal Disease: A Prospective Cohort Study. Frontiers in Medicine, 7. https://doi.org/10.3389/fmed.2020.00109

Chicago

Ying Zhang, Shi-Zhu Bian, Kun Yang, Yiqing Wang, Sha Tang, Weili Wang, Daihong Wang, Ling Nie, and Jinghong Zhao. 2020. “Baseline Soluble Anti-Erythropoietin Antibody Level Is an Independent Associated Factor for Follow-Up Erythropoietin Demand in Maintenance Dialysis Patients With End-Stage Renal Disease: A Prospective Cohort Study.” Frontiers in Medicine 7 (April). doi:10.3389/fmed.2020.00109.